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BACKGROUND: Amphibians are currently suffering a dramatic decline worldwide, mainly 
due to chytridiomycosis, a skin infection caused by the pathogenic fungus 
Batrachochytrium dendrobatidis (Bd). An important natural defense of amphibian skin is 
the production of antimicrobial peptides (AMPs) by granular glands in the dermis. AMPs 
collected from several species of frogs successfully inhibit the growth of Bd in vitro. 
Besides their anti-microbial and anti-fungal activities, AMPs have been shown to exert 
other biological effects such as anti-viral, anti-tumor, anti-oxidant, immunomodulating and 
wound healing. 
AIM: We intended to test the efficacy of AMPs as cutaneous defenses in frog species 
either resistant or susceptible to Bd. 
METHODS: 3 frog species (Gastrotheca nebulanastes (GN), G. excubitor (GE) and 
Hypsiboas gladiator (HG), were collected in montane scrub, cloud forest and high 
elevation grassland habitats near Manu National Park in southeastern Peru. AMP 
secretion was stimulated by injection of norepinephrine into the dorsal lymph sacks. AMPs 
were then purified by chromatographic techniques. The human endothelial cell line HECV 
was treated with AMP concentrations ranging from 0.005 to 50 µg/mL. Cell viability was 
verified by MTT test. Wound healing properties were analyzed by scratch wound assay. 
AMP inhibition strength against Bd growth was measured in vitro by incubating Bd 
zoospores with different concentrations of AMPs. 
RESULTS: Treatment with AMPs secreted from GN, GE and HG did not affect HECV cell 
viability at any concentration tested. No significant differences in cell migration rate were 
observed in HECV cells scratched and treated with GN and GE AMPs. Only HG peptides 
showed wound healing properties as well as strong Bd growth inhibiting ability.  
CONCLUSIONS: Stimulation of wound healing mechanisms and inhibition of Bd growth by 
skin AMPs might both contribute to HG resistance to chytridiomycosis. Understanding the 
role of skin defenses may lead to the development of novel Bd mitigation strategies. 
Possible applications of amphibian AMPs in skin medicine deserve attention and further 
studies. 
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